Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers
- 25 July 2007
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 46 (11) , 972-980
- https://doi.org/10.1002/gcc.20482
Abstract
A number of TMPRSS2/ERG fusion transcripts have been reported since the discovery that recurrent genomic rearrangements result in the fusion of TMPRSS2 and ETS family member genes. In this article we present evidence demonstrating that multiple genomic alterations contribute to the formation of various TMPRSS2/ERG transcripts. Using allele‐specific analysis of the data generated from the GeneChip 500K SNP array we observed both hemizygous and homozygous deletions occurring at different locations between and within TMPRSS2 and ERG in prostate cancers. The 500K SNP array enabled us to fine map the start and end of each deletion to specific introns of these two genes, and to predict a variety of fusion transcripts, including a new form which was confirmed by sequence analysis of the fusion transcripts in various tumors. We also inferred that translocation is an additional mechanism of fusion for these two genes in some tumors, based on largely diploid genomic DNA between TMPRSS and ERG, and different fusion transcripts produced in these tumors. Using a bioinformatics approach, we then uncovered the consensus sequences in the regions harboring the breakpoints of the deletions. These consensus sequences were homologous to the human Alu‐Sq and Alu‐Sp subfamily consensus sequences, with more than 80% homology. The presence/absence of Alu family consensus sequence in the introns of TMPRSS2 and ERG correlates with the presence/absence of fusion transcripts of theses two genes, indicating that these consensus sequences may contribute to genomic deletions and the fusion of TMPRSS2 and ERG in prostate cancer.Keywords
This publication has 21 references indexed in Scilit:
- A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosisLaboratory Investigation, 2007
- TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohortOncogene, 2007
- TMPRSS2:ERG Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor–Negative Prostate CancerCancer Research, 2006
- Diversity of TMPRSS2-ERG fusion transcripts in the human prostateOncogene, 2006
- TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN LesionsNeoplasia, 2006
- Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping arrayGenes, Chromosomes and Cancer, 2006
- Increased Tumorigenicity and Sensitivity to Ionizing Radiation upon Loss of Chromosomal Protein HMGN1Cancer Research, 2005
- dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity dataBioinformatics, 2004
- Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer familiesOncogene, 2002
- Physical Mapping of Chromosome 8p22 Markers and Their Homozygous Deletion in a Metastatic Prostate CancerGenomics, 1996